Data / Drug companies / Mometasone furoate
Mometasone furoate: 23 companies and 45 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Mometasone furoate is listed in the FDA National Drug Code Directory by 23 companies, with 45 products in commercial distribution. 33 of the products (73.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are ointment; cream; spray, metered, and the newest product started marketing on August 27, 2026.
The request: Get every company that lists mometasone furoate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 45
- Generic (ANDA) products
- 33 (73.3%)
- Application numbers
- 15
- Routes
- Topical, Nasal, Respiratory (inhalation), Intrasinal
- Brand names
- Asmanex Hfa, Asmanex, Sinuva, Allergy Relief, Allergy, Childrens Nasonex, Leader Allergy Nasal, Nasonex
- openFDA record search
- api.fda.gov
Companies that list mometasone furoate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 8 | ointment; cream | Generic drugs (ANDA) | December 11, 2008 |
| Organon LLC | 5 | aerosol; inhalant | New drug applications (NDA) | June 1, 2021 |
| Bryant Ranch Prepack | 3 | ointment; cream | Generic drugs (ANDA) | December 11, 2008 |
| Padagis Israel Pharmaceuticals Ltd | 3 | cream; ointment | Generic drugs (ANDA) | December 11, 2008 |
| Preferred Pharmaceuticals Inc. | 3 | cream; ointment | Generic drugs (ANDA) | January 27, 2026 |
| A-S Medication Solutions | 2 | cream; ointment | Generic drugs (ANDA) | July 18, 2008 |
| Cosette Pharmaceuticals, Inc. | 2 | cream; ointment | Generic drugs (ANDA) | March 4, 2014 |
| Encube Ethicals, Inc. | 2 | ointment; lotion | Generic drugs (ANDA) | April 7, 2026 |
| L. Perrigo Company | 2 | spray, metered | New drug applications (NDA) | February 7, 2023 |
| Proficient Rx LP | 2 | cream | Generic drugs (ANDA) | May 28, 2008 |
| Amazon.com Services LLC | 1 | spray, metered | New drug applications (NDA) | August 27, 2026 |
| Apotex Corp. | 1 | spray, metered | Generic drugs (ANDA) | March 22, 2016 |
| Aurohealth LLC | 1 | spray, metered | Generic drugs (ANDA) | November 22, 2024 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | December 21, 2004 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | spray, metered | New drug applications (NDA) | January 5, 2026 |
| Cardinal Health 110, LLC. DBA Leader | 1 | spray, metered | New drug applications (NDA) | September 22, 2023 |
| Golden State Medical Supply, Inc. | 1 | spray, metered | Generic drugs (ANDA) | March 22, 2016 |
| Intersect Ent, Inc. | 1 | implant | New drug applications (NDA) | February 1, 2018 |
| Proficient Rx LP | 1 | ointment | Generic drugs (ANDA) | July 18, 2008 |
| Rugby Laboratories | 1 | spray, metered | New drug applications (NDA) | October 11, 2023 |
| Sportpharm LLC | 1 | ointment | Generic drugs (ANDA) | July 18, 2008 |
| Sun Pharmaceutical Industries, Inc. | 1 | cream | Generic drugs (ANDA) | December 21, 2004 |
| Torrent Pharmaceuticals Limited | 1 | ointment | Generic drugs (ANDA) | December 15, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Ointment | 13 | 28.9% |
| Cream | 12 | 26.7% |
| Spray, metered | 9 | 20% |
| Solution | 4 | 8.9% |
| Aerosol | 3 | 6.7% |
| Inhalant | 2 | 4.4% |
| Implant | 1 | 2.2% |
| Lotion | 1 | 2.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 73.3% |
| New drug applications (NDA) | 12 | 26.7% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 45 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.